📰 Primary Endpoint News
Page 6 - Primary Endpoint News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Endpoint. Real-time updates on events, politics, business and more.
May 2, 2022
Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) - read this article along with other careers information, tips and advice on BioSpace
April 1, 2022
- Valbenazine Met the Primary Endpoint of Significant (p<0.0001) Improvement in Chorea Severity versus Placebo as Measured by the Unified Huntingtons Disease...
March 17, 2022
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports...
March 17, 2022
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray
January 14, 2022
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective,...
January 14, 2022
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective,...
December 16, 2021
Asia Market Update: Asian equity indices trade mixed after Fed decision; AU jobs data beat ests, AU yield curve flattened; European central bank decis
December 12, 2021
CAMBRIDGE, Mass. &amp; BEIJING--(BUSINESS WIRE)--Dec 12, 2021--
October 18, 2021
Biogen said that it is evaluating next steps for tofersen (BIIB067) after acknowledging that the antisense drug missed its primary endpoint in a Phase III trial in people with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).
July 19, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate VALNEVAJuly 19, 2021 GMT Saint-Herblain (France) and New York, NY, July 19, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. ...